Chemkart India Investor Presentation: Key Takeaways
H1 FY27 consolidated revenue ₹205.9 Cr (+99.4% YoY), EBITDA ₹29.4 Cr (14.3% margin), PAT ₹22.6 Cr (11.0%). EZRM SEZ CDMO facility under construction.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
7 announcements with these filters
H1 FY27 consolidated revenue ₹205.9 Cr (+99.4% YoY), EBITDA ₹29.4 Cr (14.3% margin), PAT ₹22.6 Cr (11.0%). EZRM SEZ CDMO facility under construction.
Chemkart India reported no IPO fund deviation for the half year ended 30 September 2026. Rs.39.48 Crore of Rs.64.47 Crore allocation is utilised.
Chemkart India Ltd reported revenue from operations of ₹205.9 Cr (+99.5% YoY) and net profit of ₹22.6 Cr (+121.6% YoY) for H1 FY27.
Chemkart invests Rs. 0.98 Crore in its WOS Easy Raw Materials for working capital. The related-party transaction was approved at arm's length on 27 October 2026.
Chemkart India invests Rs. 0.98 Crore in its wholly-owned subsidiary Easy Raw Materials via a rights issue. The funds support commissioning of the subsidiary's manufacturing unit.
Chemkart India Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026. The disclosure provides details of shareholder categories and promoter holdings.
Chemkart India Limited has scheduled a board meeting for October 30, 2026, to consider and approve the standalone and consolidated financial results for the half year.